Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 493 to 495 of 495 entries
Sorted by: Best Match Show Resources per page
C5 Variant rs10985126 is Associated with Mortality in Patients with Symptomatic Coronary Artery Disease.

Pharmacogenomics and personalized medicine

Henes JK, Groga-Bada P, Schaeffeler E, Winter S, Hack L, Zdanyte M, Mueller K, Droppa M, Stimpfle F, Gawaz M, Langer H, Schwab M, Geisler T, Rath D.
PMID: 34321906
Pharmgenomics Pers Med. 2021 Jul 21;14:893-903. doi: 10.2147/PGPM.S307827. eCollection 2021.

BACKGROUND: Complement component 5a (C5a) is a highly potent anaphylatoxin with a variety of pro-inflammatory effects. C5a contributes to progression of atherosclerosis and inhibition of the receptor (C5aR) might offer a therapeutic strategy in this regard. Single nucleotide polymorphisms...

Cite
Henes JK, Groga-Bada P, Schaeffeler E, et al. C5 Variant rs10985126 is Associated with Mortality in Patients with Symptomatic Coronary Artery Disease. Pharmgenomics Pers Med. 2021;14:893-903doi: 10.2147/PGPM.S307827.
Henes, J. K., Groga-Bada, P., Schaeffeler, E., Winter, S., Hack, L., Zdanyte, M., Mueller, K., Droppa, M., Stimpfle, F., Gawaz, M., Langer, H., Schwab, M., Geisler, T., & Rath, D. (2021). C5 Variant rs10985126 is Associated with Mortality in Patients with Symptomatic Coronary Artery Disease. Pharmacogenomics and personalized medicine, 14893-903. https://doi.org/10.2147/PGPM.S307827
Henes, Jessica Kristin, et al. "C5 Variant rs10985126 is Associated with Mortality in Patients with Symptomatic Coronary Artery Disease." Pharmacogenomics and personalized medicine vol. 14 (2021): 893-903. doi: https://doi.org/10.2147/PGPM.S307827
Henes JK, Groga-Bada P, Schaeffeler E, Winter S, Hack L, Zdanyte M, Mueller K, Droppa M, Stimpfle F, Gawaz M, Langer H, Schwab M, Geisler T, Rath D. C5 Variant rs10985126 is Associated with Mortality in Patients with Symptomatic Coronary Artery Disease. Pharmgenomics Pers Med. 2021 Jul 21;14:893-903. doi: 10.2147/PGPM.S307827. eCollection 2021. PMID: 34321906; PMCID: PMC8312322.
Copy Download .nbib Format: NLM
Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity.

Frontiers in immunology

Perelygina L, Faisthalab R, Abernathy E, Chen MH, Hao L, Bercovitch L, Bayer DK, Noroski LM, Lam MT, Cicalese MP, Al-Herz W, Nanda A, Hajjar J, Vanden Driessche K, Schroven S, Leysen J, Rosenbach M, Peters P, Raedler J, Albert MH, Abraham RS, Rangarjan HG, Buchbinder D, Kobrynski L, Pham-Huy A, Dhossche J, Cunningham Rundles C, Meyer AK, Theos A, Atkinson TP, Musiek A, Adeli M, Derichs U, Walz C, Krüger R, von Bernuth H, Klein C, Icenogle J, Hauck F, Sullivan KE.
PMID: 35003119
Front Immunol. 2021 Dec 20;12:796065. doi: 10.3389/fimmu.2021.796065. eCollection 2021.

Rubella virus (RuV) has recently been found in association with granulomatous inflammation of the skin and several internal organs in patients with inborn errors of immunity (IEI). The cellular tropism and molecular mechanisms of RuV persistence and pathogenesis in...

Cite
Perelygina L, Faisthalab R, Abernathy E, et al. Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity. Front Immunol. 2021;12:796065doi: 10.3389/fimmu.2021.796065.
Perelygina, L., Faisthalab, R., Abernathy, E., Chen, M. H., Hao, L., Bercovitch, L., Bayer, D. K., Noroski, L. M., Lam, M. T., Cicalese, M. P., Al-Herz, W., Nanda, A., Hajjar, J., Vanden Driessche, K., Schroven, S., Leysen, J., Rosenbach, M., Peters, P., Raedler, J., Albert, M. H., Abraham, R. S., Rangarjan, H. G., Buchbinder, D., Kobrynski, L., Pham-Huy, A., Dhossche, J., Cunningham Rundles, C., Meyer, A. K., Theos, A., Atkinson, T. P., Musiek, A., Adeli, M., Derichs, U., Walz, C., Krüger, R., von Bernuth, H., Klein, C., Icenogle, J., Hauck, F., & Sullivan, K. E. (2021). Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity. Frontiers in immunology, 12796065. https://doi.org/10.3389/fimmu.2021.796065
Perelygina, Ludmila, et al. "Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity." Frontiers in immunology vol. 12 (2021): 796065. doi: https://doi.org/10.3389/fimmu.2021.796065
Perelygina L, Faisthalab R, Abernathy E, Chen MH, Hao L, Bercovitch L, Bayer DK, Noroski LM, Lam MT, Cicalese MP, Al-Herz W, Nanda A, Hajjar J, Vanden Driessche K, Schroven S, Leysen J, Rosenbach M, Peters P, Raedler J, Albert MH, Abraham RS, Rangarjan HG, Buchbinder D, Kobrynski L, Pham-Huy A, Dhossche J, Cunningham Rundles C, Meyer AK, Theos A, Atkinson TP, Musiek A, Adeli M, Derichs U, Walz C, Krüger R, von Bernuth H, Klein C, Icenogle J, Hauck F, Sullivan KE. Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity. Front Immunol. 2021 Dec 20;12:796065. doi: 10.3389/fimmu.2021.796065. eCollection 2021. PMID: 35003119; PMCID: PMC8728873.
Copy Download .nbib Format: NLM
BOB.1/OBF.1 is required during B-cell ontogeny for B-cell differentiation and germinal center function.

European journal of immunology

Betzler AC, Fiedler K, Hoffmann TK, Fehling HJ, Wirth T, Brunner C.
PMID: 34918350
Eur J Immunol. 2021 Dec 08; doi: 10.1002/eji.202149333. Epub 2021 Dec 08.

BOB.1/OBF.1 is a lymphocyte-specific transcriptional co-activator of octamer-dependent transcription. It regulates the expression of genes important for lymphocyte physiology together with the Oct-1 and Oct-2 transcription factors. So far, BOB.1/OBF.1 has been studied in conventional knockout mice, whereby a...

Cite
Betzler AC, Fiedler K, Hoffmann TK, et al. BOB.1/OBF.1 is required during B-cell ontogeny for B-cell differentiation and germinal center function. Eur J Immunol. 2021;doi: 10.1002/eji.202149333.
Betzler, A. C., Fiedler, K., Hoffmann, T. K., Fehling, H. J., Wirth, T., & Brunner, C. (2021). BOB.1/OBF.1 is required during B-cell ontogeny for B-cell differentiation and germinal center function. European journal of immunology, . https://doi.org/10.1002/eji.202149333
Betzler, Annika C, et al. "BOB.1/OBF.1 is required during B-cell ontogeny for B-cell differentiation and germinal center function." European journal of immunology vol. (2021). doi: https://doi.org/10.1002/eji.202149333
Betzler AC, Fiedler K, Hoffmann TK, Fehling HJ, Wirth T, Brunner C. BOB.1/OBF.1 is required during B-cell ontogeny for B-cell differentiation and germinal center function. Eur J Immunol. 2021 Dec 08; doi: 10.1002/eji.202149333. Epub 2021 Dec 08. PMID: 34918350.
Copy Download .nbib Format: NLM
Showing 493 to 495 of 495 entries